Real-time enrollment status for this resectable hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: September 7, 2026 at 12:38 AM UTC
| NCT Number | NCT07446257 |
| Recruiting Status | Recruiting |
| Condition | Resectable Hepatocellular Carcinoma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Texas Southwestern Medical Center |
| Last Updated on CT.gov | September 3, 2026 (4 days ago) |
As of September 7, 2026: Clinical trial NCT07446257 is currently recruiting participants. This early_phase1 study for resectable hepatocellular carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Texas Southwestern Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07446257 is actively recruiting participants as of September 7, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07446257 was last updated 4 days ago (September 3, 2026). HelloStudys verifies this status automatically.